UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma

Nature communications, 2019-11, Vol.10 (1), p.5367-16, Article 5367

2019

Volltextzugriff (PDF)

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade

JNCI : Journal of the National Cancer Institute, 2018-07, Vol.110 (7), p.787-790

2018

Volltextzugriff (PDF)

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma

Nature communications, 2017-10, Vol.8 (1), p.990-9, Article 990

2017

Volltextzugriff (PDF)

Absolute quantification of somatic DNA alterations in human cancer

Nature biotechnology, 2012-05, Vol.30 (5), p.413-421

2012

Volltextzugriff (PDF)

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines

Clinical cancer research, 2020-08, Vol.26 (15), p.3908-3917

2020

Volltextzugriff (PDF)

Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma

JNCI : Journal of the National Cancer Institute, 2014-09, Vol.106 (9), p.1

2014

Volltextzugriff (PDF)

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations

Modern pathology, 2015-04, Vol.28 (4), p.505-514

2015

Volltextzugriff (PDF)

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers

Science translational medicine, 2013-01, Vol.5 (167), p.167ra4

2013

Volltextzugriff (PDF)

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

JNCI : Journal of the National Cancer Institute, 2012-10, Vol.104 (19), p.1503-1513

2012

Volltextzugriff (PDF)

Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing

Cancer, 2017-09, Vol.123 (17), p.3261-3268

2017

Volltextzugriff (PDF)

Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study

Cancer prevention research (Philadelphia, Pa.), 2018-11, Vol.11 (11), p.697-706

2018

Volltextzugriff (PDF)

Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant

Science advances, 2018-04, Vol.4 (4), p.eaaq1090-eaaq1090

2018

Volltextzugriff (PDF)

Evaluating cell lines as tumour models by comparison of genomic profiles

Nature communications, 2013-07, Vol.4 (1), p.2126-2126, Article 2126

2013

Volltextzugriff (PDF)

Uterine adenosarcomas are mesenchymal neoplasms

The Journal of pathology, 2016-02, Vol.238 (3), p.381-388

2016

Volltextzugriff (PDF)

Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (14), p.5901-5911

2010

Volltextzugriff (PDF)

Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening

Proceedings of the National Academy of Sciences - PNAS, 2021-06, Vol.118 (25), p.1-12

2021

Volltextzugriff (PDF)

Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers

Nature communications, 2019-09, Vol.10 (1), p.4369-12, Article 4369

2019

Volltextzugriff (PDF)

Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers

Clinical cancer research, 2005-04, Vol.11 (8), p.2875-2878

2005

Volltextzugriff (PDF)

Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity

Cancer research (Chicago, Ill.), 2015-04, Vol.75 (7), p.1495-1503

2015

Volltextzugriff (PDF)

Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth

ACS chemical biology, 2017-08, Vol.12 (8), p.2085-2096

2017

Volltextzugriff (PDF)

New insights into PARP inhibitors' effect on cell cycle and homology-directed DNA damage repair

Molecular cancer therapeutics, 2014-06, Vol.13 (6), p.1645-1654

2014

Volltextzugriff (PDF)

A Differentiation-Based MicroRNA Signature Identifies Leiomyosarcoma as a Mesenchymal Stem Cell-Related Malignancy

The American journal of pathology, 2010-08, Vol.177 (2), p.908-917

2010

Volltextzugriff (PDF)

Inferring tumour purity and stromal and immune cell admixture from expression data

Nature communications, 2013-10, Vol.4 (1), p.2612-2612, Article 2612

2013

Volltextzugriff (PDF)

Endometrial cancer

Nature reviews. Disease primers, 2021-12, Vol.7 (1), p.88-88, Article 88

2021

Volltextzugriff (PDF)

Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

Clinical cancer research, 2009-04, Vol.15 (7), p.2448-2455

2009

Volltextzugriff (PDF)

1 – 25 von 674

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(554)
Mit Volltextzugriff
(537)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(668)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma

Absolute quantification of somatic DNA alterations in human cancer

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines

Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing

Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study

Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant

Evaluating cell lines as tumour models by comparison of genomic profiles

Uterine adenosarcomas are mesenchymal neoplasms

Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer

Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening

Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers

Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers

Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity

Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth

New insights into PARP inhibitors' effect on cell cycle and homology-directed DNA damage repair

A Differentiation-Based MicroRNA Signature Identifies Leiomyosarcoma as a Mesenchymal Stem Cell-Related Malignancy

Inferring tumour purity and stromal and immune cell admixture from expression data

Endometrial cancer

Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

Aktive Filter

Suchergebnisse filtern